Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Dec 2021 for Reneo Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySaleVineet R. Jindal
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Vineet R. Jindal: trading record in brief
Vineet R. Jindal (finance chief) discloses dealings in OnKure Therapeutics, Inc. to SEC (Form 4). In total, 2 filings cover trades dated from 25 August 2021 to 10 December 2021.
Every open-market trade on record is a purchase: 1 purchase worth €32k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant.
The newest entry dates from 14 December 2021: a share grant, in OnKure Therapeutics, Inc. The clock since the last published purchase (26 August 2021) now reads 1,879 days. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Vineet R. Jindal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
30,000 shares0Common StockSEC:0001209191-21-069448:0
5,000 shares@ US$7.4353100.0% of flowCommon StockSEC:0001209191-21-053523:0
Canonical exit: 23 Nov 2021 (T+90)
2 of 2 declarations
